Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05964166 · ClinicalTrials.gov registry record · NA
Tetragraph® Monitor: Tolerance of Preoperative Placement
A NA study, sponsored by Joseph D. Tobias.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT05964166 is a NA study that has completed, run by Joseph D. Tobias. The registered enrollment target is 40 participants.
The verdict
NCT05964166, a NA study, has completed, sponsored by Joseph D. Tobias.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
This is a prospective, non-blinded, single arm study. The primary objective of this study is to evaluate the tolerance to preoperative placement of the adhesive sensor for the Tetragraph® Neuromuscular Transmission Monitor in pediatric-sized patients ≤ 12 years of age.
Interventions
- DEVICE TetraGraph NMT Monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2023-05-31 |
| Est. Completion | 2023-08-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05964166
The ClinicalTrials.gov registry entry for NCT05964166 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Joseph D. Tobias, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TetraGraph NMT Monitor is the first listed.
NCT05964166 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05964166 about?
NCT05964166 is a clinical study titled "Tetragraph® Monitor: Tolerance of Preoperative Placement". This is a prospective, non-blinded, single arm study. The primary objective of this study is to evaluate the tolerance to preoperative placement of the adhesive sensor for the Tetragraph® Neuromuscular Transmission Monitor in pediatric-sized patients ≤ 12 years of age.
What is the current status of trial NCT05964166?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2023-05-31. Estimated completion is 2023-08-01.
What interventions are being tested in trial NCT05964166?
The interventions under investigation include: TetraGraph NMT Monitor (DEVICE).
Who is sponsoring clinical trial NCT05964166?
This trial is sponsored by Joseph D. Tobias, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.